Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

InstaSure™ Non-Invasive Finger-Press Point-of-Care Screening Test for Hepatocellular Carcinoma

NCT07848750 is registered in ClinicalTrials.gov with Beijing Municipal Administration of Hospitals as lead sponsor.

NCT NCT07848750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
InstaSure™ Non-Invasive Finger-Press Point-of-Care Screening Test for Hepatocellular Carcinoma
Lead sponsor
Beijing Municipal Administration of Hospitals
Phase
Observational
Overall status
Recruiting
Start date
June 30, 2026
Completion date
December 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma